Navigation Links
FlexiPlate siRNA

For highly flexible, economical RNAi screening


FlexiPlate siRNA is a giant leap forward for more flexible RNAi screening. FlexiPlate siRNA can be ordered at 0.1 nmol, 0.25 nmol, and 1 nmol scales in 96-well plates for your choice of target genes. For maximum flexibility, select siRNAs and specify plate layout at the GeneGlobe Web portal.


Advantages of FlexiPlate siRNA:

Maximum flexibility select siRNAs targeting human and mouse genes, controls, scales, and plate layout

Economical screening screen more target genes within budget

Fast and easy access simply visit www.qiagen.com/GeneGlobe to create and save plates

Cutting-edge siRNA design HP OnGuard siRNA Design minimizes the risk of off-target effects and maximizes knockdown potency

Rapid delivery enabling screening without delay


Maximum flexibility and economical options
FlexiPlate siRNA allows design of RNAi screening experiments to suit specific requirements. siRNAs for any human or mouse gene can be selected as well as any positive and negative controls required. HP GenomeWide siRNAs, for human or mouse genes or HP Validated siRNAs, which have been shown by real-time RT-PCR to provide at least 70% knockdown, can be selected. With the user-friendly Web interface, siRNAs and controls can be placed in any of the wells of a 96-well plate or plate layout can be selected from a range of predefined layout patterns (Figure 1). siRNAs are provided in 0.1 nmol, 0.25 nmol, or 1 nmol scales, enabling economical screening using low or higher siRNA amounts, as required.


Easy access
At QIAGENs GeneGlobe Web portal, it is easy to search for siRNAs for genes of interest and to arrange plate layouts to suit screening experiments. Lists of gene names, Entrez Gene IDs, RefSeq IDs, siRNA names, or catalog numbers can be uploaded, making the process of plate ordering fast and easy. Plates can be ordered immediately or saved for later changes or ordering. Plate layouts can also be downloaded for your records (Figure 1).


Easily Create and Order FlexiPlate siRNA

Figure 1 Create plates at www.qiagen.com/GeneGlobe


Cutting-edge siRNA design
New advances in the siRNA design process ensure that QIAGENs highly innovative and sophisticated HP OnGuard siRNA Design delivers potent and specific siRNA. siRNAs are designed using neural-network technology based on an extremely large set of data from RNAi experiments (1). siRNA design is then checked for homology to all other sequences of the genome using an up-to-date, nonredundant sequence database and a proprietary homology analysis tool which incorporates exciting new features (Figure 2).


New design features:
siRNA target sequence from up-to-date NCBI databases
siRNAs are designed against the most up-to-date gene sequences from the NCBI. Using the latest sequence information ensures accurate design and potent knockdown.

3' UTR/seed region analysis
Several studies have shown that off-target effects are frequently caused by matches of the seed region of the siRNA antisense strand with the 3' untranslated region of mRNA (2). siRNA designs are analyzed for 3' UTR/seed region complementarity and siRNAs with the least potential to cause off-target effects are selected.

SNP avoidance
siRNA design is optimized to avoid all known single nucleotide polymorphisms (SNPs) using the RefSNP database. This increases siRNA potency, as an siRNA spanning a SNP will vary in its effectiveness.

Interferon motif avoidance
siRNAs are screened for multiple sequence motifs known to result in an interferon response (3, 4). siRNAs with such motifs are rejected.


The complete solution for high-throughput RNAi
In addition to FlexiPlate siRNA, QIAGEN offers a comprehensive range of solutions for high-throughput RNAi. HiPerFect Transfection Reagent provides exceptionally high transfection efficiency using low siRNA concentrations, minimizing the risk of off-target effects and reducing costs, as less siRNA is used.

Rapid mRNA purification from large numbers of cell samples can be easily achieved using TurboCapture mRNA Kits which are ideal for high-throughput screening.

QuantiTect Primer Assays are ready-to-use primer sets for quantitative, real-time RT-PCR using SYBR Green based detection. They are available for every human and mouse gene. When used in combination with QuantiTect SYBR Green Kits, accurate and sensitive real-time RT-PCR is assured. Contact your QIAGEN sales representative or visit www.qiagen.com/siRNA for more information on these and other products for high-throughput RNAi to suit your needs.


References
1. Huesken, D. et al. (2005) Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23, 995.

2. Farh, K.K. et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310, 1817.

3. Judge, A.D., Sood, V., Shaw, J.R., Fang, D., McClintock, K., and MacLachlan, I. (2005) Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol. 23, 457.

4. Hornung, V. et al. (2005) Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 11, 263.



Experience maximum flexibility at www.qiagen.com/GeneGlobe !


back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Custom and library siRNA for efficient gene silencing
2. Custom and library siRNA for efficient gene silencing
3. Cancer siRNA Oligo Set Version 1.0
4. Library siRNA
5. Custom siRNA Oligo Synthesis Service
6. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
7. Quantification of siRNA Silencing Efficiency Using the LightCycler System
8. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
9. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection
10. siRNA transfection optimization with the Agilent 2100 bioanalyzer
11. siRNA Design Guidelines

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FlexiPlate siRNA

(Date:11/26/2009)...LAFAYETTE, Ind. - A new generation of ultrasmall t...tiny structures called semiconducting nanowires ar...rchers at IBM, Purdue University and the Universit...s have learned how to create nanowires with layers...t the atomic level, which is a critical requiremen...
(Date:11/25/2009)... MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochroma to...to its Board of Directors. Dr. Moldt will replace ...the Company,s Board. The number of Board members r...y pleased to welcome Peter Moldt to the board and ... guidance as Cytochroma continues to make progress...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IE... electrical and communications systems and service...arkets, announced today that its commercial busine...n Torcon JV to install the electrical systems for ...ility at the U.S. Army Medical Research Institute ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...arch 14 ,Renovis, Inc. (Nasdaq: RNVS ), a biophar...velopment of drugs for major medical needs in the ...oday announced financial results,for the fourth qu...for the fourth quarter and the year ended December...ctively, compared to $2.2 million and,$10.4 millio...
... Diagnostics,Incorporated (NYSE: DGX ), the natio...ation and services, announced that it is scheduled...lobal Healthcare Conference on,Wednesday, March 19...rida.,The Quest Diagnostics presentation is schedu...entation will be webcast live during the conferenc...
... Inc. (Nasdaq:,NUVA), a medical device company foc...ve surgical treatments for the spine, announced to...nd Chief Financial Officer,is scheduled to present...lthcare Conference at the Loews Miami Beach Hotel ... 10:15 a.m. ET., A live Web cast of the presentat...
Other Biology Technology:Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 2Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 3Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 4Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 5Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 6Renovis Reports Fourth Quarter and Full Year 2007 Financial Results 7Quest Diagnostics to Speak at Lehman Brothers 11th Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 2NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference 3
(Date:11/24/2009)...ened and flabby arteries from collapsing have been...nts are no longer needed -- once the arteries are ... doctors had no choice but to leave them in place....,s Department of Biomedical Engineering has develo...es drugs where they,re needed, then dissolves. , ...
(Date:11/24/2009)...ORK (November 24, 2009) -- The Wildlife Conservati...g that the last remaining population of Siberian t... rising tide of poaching and habitat loss. , ...ian officials of what needs to be done to protect ... , The report was released by the Si...
(Date:11/24/2009)...ber 24, 2009) New research on bacterial communiti...veals predictable temporal patterns, suggesting th...rs for monitoring climate change in the polar regi...dings of the National Academy of Sciences Early E...x rivers shifted synchronously over time, correlat...
Breaking Biology News(10 mins):A coating for life 2Report shows dramatic decline in Siberian tigers 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes 13588 1SynCo Bio Partners to Manufacture Versartis Novel Drug for Type 2 Diabetes 13588 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4For Short Kids No Lack of Self Esteem 54617 1For Short Kids No Lack of Self Esteem 54617 2For Short Kids No Lack of Self Esteem 54617 3
...most common form of lung cancer may begin in a gro... researchers from the Howard Hughes Medical Instit...isolated a novel type of lung cell that can divide... specialized kinds of cells deep in the lung. Thei...umor development, the stem cell appears to be the ...
...archers working with rats have zeroed in on the br...es to the impulsive behavior seen in users of coca...me circuitry has been implicated in such disorders...stress disorder, wrote the researchers. , Yukiori ...tsburgh described their findings in the July 21, 2...
...mbination of the drugs ribavirin and interferon is... interferon alone, but it also increases the risk ...iew of recent evidence. , "Adding ribavirin to any...ment of choice for patients with hepatitis C," con...gen University Hospital. , However, the authors c...
Other Biology News:Most common lung cancers may begin in newly discovered cells 2Most common lung cancers may begin in newly discovered cells 3Most common lung cancers may begin in newly discovered cells 4New clue to cocaine addicts' quirky behavior 2Hepatitis C responds best to combo of ribavirin and interferon, study concludes 2Hepatitis C responds best to combo of ribavirin and interferon, study concludes 3
...one of the human Topoisomerase II gene. Descri...te of nucleic acids by passing an intact DNA helix...ate DNA helix (1,2) . As a result of its double-st... negatively or positively supercoiled DNA, as well...
...t is a genetically engineered Klenow polymerase in...moved, leaving only the 5 to 3 polymerase activity...o- Klenow Fragment the enzyme of choice for isotop...primed method, and for DNA sequencing by the Sange...
Klenow Enzyme; labeling grade, DNA Polymerase I, large fragment from Roche Applied Science
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
Biology Products: